Cencora, Inc. (COR) Stock Price

CORStock

$322.03+11.09%52W

Market Cap$61.45B

P/E38.07x

PEG Ratio0.67

Div yield1.01%

Beta0.57

COR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-23.55%

Price vs S&P 500 (4W)2.89%

PEG Ratio0.67

VGM Score56.69

P/E Ratio (Annual)38.07x

Indicated Dividend Yield (Annual)1.01%

P/CF (Annual)15.27x

Book Value / Share (Quarterly)$15.99

P/TBV (Annual)7.70x

Indicated Dividend (Annual)$2.40

Revenue Growth (3Y)10.43%

Cash Flow / Share (Quarterly)$21.11

Payout Ratio (TTM)12.16%

Price vs S&P 500 (YTD)-17.48%

Gross Margin (TTM)3.98%

Net Profit Margin (TTM)0.79%

EPS (TTM)$13.45

10-Day Avg Trading Volume0.97M

EPS Excl Extra (TTM)$13.45

Revenue Growth (5Y)11.09%

EPS (Annual)$7.96

Dividend / Share (Annual)$2.25

ROI (Annual)16.95%

Gross Margin (Annual)3.51%

Net Profit Margin (5Y Avg)0.62%

Cash / Share (Quarterly)$14.75

P/E Basic Excl Extra (TTM)22.54x

Revenue Growth QoQ (YoY)5.07%

P/E Normalized (Annual)38.07x

ROA (Last FY)2.03%

Revenue Growth TTM (YoY)5.09%

EBITD / Share (TTM)$20.96

ROE (5Y Avg)278.25%

Operating Margin (TTM)0.91%

Cash Flow / Share (Annual)$16.54

P/B Ratio19.39x

P/B Ratio (Quarterly)18.05x

Net Income / Employee (Annual)$30,500

EV / Revenue (TTM)0.20x

Net Interest Coverage (TTM)8.59x

ROA (TTM)3.28%

EPS Growth QoQ (YoY)11.81%

EV / EBITDA (TTM)16.68x

EPS Incl Extra (Annual)$7.96

Current Ratio (Annual)0.90x

Quick Ratio (Quarterly)0.57x

3-Month Avg Trading Volume1.68M

52-Week Price Return11.09%

EV / Free Cash Flow (Annual)21.22x

P/E Incl Extra (TTM)22.54x

Revenue / Employee (TTM)$6,524,900

Tangible BV / Share (Quarterly)$9.54

P/S Ratio (Annual)0.18x

Asset Turnover (Annual)4.20x

52-Week High$377.54

Operating Margin (5Y Avg)0.92%

EPS Excl Extra (Annual)$7.96

CapEx CAGR (5Y)12.56%

Tangible BV CAGR (5Y)-26.12%

26-Week Price Return-11.62%

Quick Ratio (Annual)0.54x

13-Week Price Return20.29%

Total Debt / Equity (Annual)5.08x

Current Ratio (Quarterly)0.93x

Enterprise Value$68.07B

Revenue / Share Growth (5Y)12.19%

Asset Turnover (TTM)4.15x

Book Value / Share Growth (5Y)-10.80%

Revenue / Employee (Annual)$6,300,600

Inventory Turnover (Annual)15.70x

Pretax Margin (Annual)0.70%

Cash / Share (Annual)$22.46

3-Month Return Std Dev26.74%

Gross Margin (5Y Avg)3.37%

Net Income / Employee (TTM)$51,500

EBITDA Interim CAGR (5Y)13.19%

ROE (Last FY)103.06%

Net Interest Coverage (Annual)6.41x

EPS Basic Excl Extra (Annual)$7.96

P/FCF (TTM)9.17x

Receivables Turnover (TTM)12.55x

EV / Free Cash Flow (TTM)16.90x

Total Debt / Equity (Quarterly)3.84x

EPS Incl Extra (TTM)$13.45

Receivables Turnover (Annual)12.38x

ROI (TTM)21.19%

Dividend Growth Rate (5Y)6.10%

P/S Ratio (TTM)0.18x

Pretax Margin (5Y Avg)0.83%

Revenue / Share (Annual)$1646.05

Tangible BV / Share (Annual)$2.82

Forward P/E16.03x

Free OCF CAGR (5Y)11.79%

Price vs S&P 500 (52W)-7.47%

P/E Ratio (TTM)22.54x

EPS Growth TTM (YoY)38.37%

Year-to-Date Return-4.65%

5-Day Price Return-0.54%

EPS Normalized (Annual)$7.96

ROA (5Y Avg)2.55%

Net Profit Margin (Annual)0.48%

Month-to-Date Return3.43%

Cash Flow / Share (TTM)$13.26

EBITD / Share (Annual)$18.85

EPS Growth (3Y)-0.38%

Operating Margin (Annual)0.82%

LT Debt / Equity (Annual)5.00x

P/CF (TTM)12.35x

ROI (5Y Avg)22.74%

P/E Excl Extra (TTM)22.54x

LT Debt / Equity (Quarterly)3.75x

EPS Basic Excl Extra (TTM)$13.45

P/TBV (Quarterly)2.36x

Payout Ratio (Annual)28.12%

P/B Ratio (Annual)40.18x

Dividend / Share (TTM)$2.43

Inventory Turnover (TTM)15.52x

Pretax Margin (TTM)1.08%

Book Value / Share (Annual)$7.78

Price vs S&P 500 (13W)18.34%

Dividend Yield (TTM)0.79%

Beta0.57x

P/FCF (Annual)18.45x

Revenue / Share (TTM)$1715.81

ROE (TTM)106.43%

52-Week Low$244.82

vGradeC

gGradeB

mGradeB

vgmGradeC

COR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$4.34	$4.48	+3.22%(+$0.14)
Q1 2026	May 6, 2026	$4.73	$4.75	+0.48%(+$0.02)
Q4 2025	Feb 4, 2026	$4.04	$4.08	+0.99%(+$0.04)
Q3 2025	Nov 5, 2025	$3.79	$3.84	+1.44%(+$0.05)
Q2 2025	Aug 6, 2025	$3.84	$4.00	+4.24%(+$0.16)

COR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

4.05

4.00

Industry Peers — Drug Wholesale(10)

Symbol	Value Score	Growth Score	Momentum Score	Price
CORCencora, Inc.	C	B	B	$322.03
MCKMcKesson Corporation	D	B	B	$893.39
CAHCardinal Health, Inc.	D	C	B	$234.55
HLFHerbalife Ltd.	B	D	C	$12.43
NUSNuSkin Enterprises, Inc.	A	F	D	$4.85
ZSTKZeroStack Corp. Common Stock	—	D	C	$5.41
WGRXWellgistics Health, Inc. Common Stock	D	F	F	$1.17
COSMCosmos Holdings Inc. Common Stock	C	B	D	$0.22
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares	—	F	F	$0.35
HWHHWH International Inc. Common Stock	F	D	B	$1.85
MEDSDataMeds AI, Inc. Common Stock	B	D	D	$0.96

About Cencora, Inc.

Cencora is one of three dominant pharmaceutical wholesalers in the US, distributing branded, generic, and specialty drugs to pharmacies, hospitals, and healthcare providers. The company and its two main competitors control over 90% of the US pharmaceutical wholesale market. Beyond core distribution, Cencora generates revenue through commercialization services for pharmaceutical and medical device manufacturers, specialty logistics (World Courier), and animal health distribution (MWI Animal Health). The company strengthened its international footprint through the 2021 acquisition of Alliance Healthcare, a leading European pharmaceutical wholesaler.